These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ. Scand J Gastroenterol; 2008 May 18; 43(9):1128-36. PubMed ID: 18609175 [Abstract] [Full Text] [Related]
10. [Clinical, biochemical, and morphological characteristics of chronic hepatitis with various etiology]. Masevich TsG, Ermolaeva LG. Ter Arkh; 2002 May 18; 74(2):35-7. PubMed ID: 11899821 [Abstract] [Full Text] [Related]
14. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K. Am J Med; 2007 Mar 18; 120(3):280.e9-14. PubMed ID: 17349453 [Abstract] [Full Text] [Related]
15. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study. Elsebae MM, Abu-Zekri NB. Int J Surg; 2008 Oct 18; 6(5):362-6. PubMed ID: 18662898 [Abstract] [Full Text] [Related]
17. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma. Chen CH, Lin ST, Kuo CL, Nien CK. Hepatogastroenterology; 2008 Oct 18; 55(85):1423-7. PubMed ID: 18795704 [Abstract] [Full Text] [Related]